RxDoctor Payments Data

Mu Qiao, MD

Hospitalist · Gig Harbor, WANPI 1992947063

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 25 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$500in general payments, 2019–2025

Across 25 payments — averaging $19.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$99
  • Bayer$67
  • Novo Nordisk$63
  • Daiichi Sankyo Inc.$61
  • Biohaven Pharmaceuticals, Inc.$43
  • Nestle Healthcare Nutrition Inc.$26
  • plus $141 from 8 others

What the payments were for

  • Food & beverage$500100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$500 in reported general payments places this provider in the 95th percentile of 661 hospitalist providers in Washington.

See all hospitalist providers in Washington

Medicare billing

Part B allowed, 2024
$74,791
Medicare patients
275
Services billed
721

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban21$13,341
Quetiapine Fumarate12$1,272
Atorvastatin Calcium20$248
ClopidogrelClopidogrel Bisulfate16$206
Carvedilol22$205
Amlodipine Besylate38$171
Metoprolol Succinate19$167
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$137
Amiodarone Hcl11$126
Losartan Potassium13$117
Oxycodone Hcl13$73
Pantoprazole Sodium13$54
Furosemide14$52
Lisinopril13$49
Metoprolol Tartrate14$28

Paid to pharmacies, not to this prescriber.

Other hospitalist in Gig Harbor

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →